1298
Valík, Matějka, Herdtweck, Král, Dolenský:
(6R*,9R*,15R*,18R*)-3,12-Dimethoxy-16,17-dihydro-5H,10H-6,18:9,15-dimethanobenzo-
3
[1,2-c:6,5-c′]bis[1,5]benzodiazocine (4a). 1H NMR (CDCl3): 6.98 d, 2 H, JHH = 8.8 (H3, H16);
3
4
4
6.90 s, 2 H (H12, H25); 6.67 dd, 2 H, JHH = 8.8, JHH = 2.8 (H2, H15); 6.35 d, 2 H, JHH = 2.8
(H6, H19); 4.54 d, 2 H, JHH = 16.6 (H7b, H20b); 4.22 d, 2 H, JHH = 16.7 (H9b, H22b); 4.13 d,
2
2
2 H, JHH = 12.4 (H8a, H21a); 4.05 d, 2 H, JHH = 12.4 (H8b, H21b); 4.04 d, 2 H, JHH = 16.6
2
2
2
(H7a, H20a); 3.73 d, 2 H, JHH = 16.7 (H9a, H22a); 3.62 s, 6 H (H13, H26). 13C NMR (CDCl3):
2
156.1 (C1, C14), 143.7 (C11, C24), 140.9 (C4, C17), 128.7 (C5, C18), 126.0 (C3, C16), 124.9 (C10
,
C23), 124.2 (C12, C25), 113.9 (C2, C15), 110.8 (C6, C19), 66.3 (C8, C21), 58.4 (C7, C20), 55.8
(C9, C22), 55.3 (C13, C26). For atom n um berin g, see Fig. 1 an d for ch em ical sh ifts in oth er
solven ts, see Tables VIII an d IX. M.p. 254–258 °C with decom position . For C26H26N4O2
(426.5) calculated: 73.22% C, 6.14% H, 13.14% N; foun d: 72.85% C, 6.20% H, 12.90% N.
HRMS (FAB+): for C26H26N4O2 (MH+) calculated: 427.2134; foun d: 427.2124.
(6R*,9S*,15S*,18R*)-3,12-dimethoxy-16,17-dihydro-5H,10H-6,18:9,15-dimetha nobenzo-
3
[1,2-c:6,5-c′]bis[1,5]benzodiazocine (4b). 1H NMR (CDCl3): 6.94 d, 2 H, JHH = 8.8 (H3, H16);
3
4
4
6.91 s, 2 H (H12, H25); 6.61 dd, 2 H, JHH = 8.8, JHH = 2.9 (H2, H15); 6.32 d, 2 H, JHH = 2.9
(H6, H19); 4.56 d, 2 H, JHH = 16.8 (H7b, H20b); 4.28 d, 2 H, JHH = 17.0 (H9b, H22b); 4.11 d,
2
2
2 H, JHH = 12.6 (H8a, H21a); 4.02 d, 2 H, JHH = 16.8 (H7a, H20a); 4.02 d, 2 H, JHH = 12.6
2
2
2
(H8b, H21b); 3.72 d, 2 H, JHH = 17.0 (H9a, H22a); 3.59 s, 6 H (H13, H26). 13C NMR (CDCl3):
2
156.1 (C1, C14), 143.7 (C11, C24), 141.1 (C4, C17), 128.7 (C5, C18), 126.2 (C3, C16), 124.7 (C10
,
C23), 124.1 (C12, C25), 113.9 (C2, C15), 110.7 (C6, C19), 66.4 (C8, C21), 58.1 (C7, C20), 55.8
(C9, C22), 55.3 (C13, C26). For atom n um berin g, see Fig. 1 an d for ch em ical sh ifts in oth er
solven ts, see Tables VIII an d IX. M.p. 271–281 °C with decom position . For C26H26N4O2
(426.5) calculated: 73.22% C, 6.14% H, 13.14% N; foun d: 72.68% C, 6.26% H, 12.96% N.
HRMS (FAB+): for C26H26N4O2 (MH+) calculated: 427.2134; foun d: 427.2124.
On e-Pot Preparation of 4a an d 4b
A vial was ch arged with 1,4-ph en ylen ediam in e (105 m g, 0.97 m m ol), 4-m eth oxyan ilin e
(344 m g, 2.79 m m ol) an d h exam eth ylen etetram in e (260 m g, 1.85 m m ol), an d TFA (4 m l)
was added. Th e m ixture was stirred at 80 °C for 18 h . After coolin g th e m ixture was treated
with m eth ylen e ch loride an d water, an d n eutralized by addin g solid NaHCO3, an d alkalized
by addin g con cen trated aqueous am m on ia. Th e aqueous layer was extracted with CH2Cl2,
th e com bin ed organ ic layers were dried over an h ydrous Na2SO4 an d evaporated to dryn ess
in vacuo. Th e com plex m ixture was separated by repeated colum n ch rom atograph y on silica
usin g a CH2Cl2/m eth an ol m ixture (from 1:0 to 9:1) to obtain 9 m g (2%) of form yl-TB 7,
74 m g (19%) of m on o-TB 6 an d 29 m g (7%) of bis-TB 4 (4a/4b 2:1).
2,8-Dimethoxy-6H,12H-5,11-methanodibenzo[b,f][1,5]diazocine-4-carbaldehyde (7). 1H NMR
4
3
(CDCl3): 10.57 s, 1 H (H18); 7.22 d, 1 H, JHH = 3.0 (H13); 7.08 d, 1 H, JHH = 8.8 (H3);
6.77 dd, 1 H, JHH = 8.8, JHH = 2.9 (C2); 6.71 d, 1 H, JHH = 3.0 (H15); 6.41 d, 1 H, JHH = 2.9
(H6); 4.80 d, 1 H, JHH = 16.8 (H7b); 4.69 d, 1 H, JHH = 16.8 (H9b); 4.35 d, 1 H, JHH = 12.8
3
4
4
4
2
2
2
(H8); 4.34 d, 1 H, JHH = 12.8 (H8); 4.14 d, 1 H, JHH = 16.8 (H9a); 3.97 d, 1 H, JHH = 16.8
(H7a); 3.75 s, 3 H (H16); 3.70 s, 3 H (H17). 13C NMR (CDCl3): 190.9 (C18), 156.3 (C1), 155.9
(C14), 144.6 (C11), 140.6 (C4), 130.3 (C10), 128.1 (C5), 126.1 (C3), 122.5 (C12), 119.6 (C15),
114.4 (C2), 110.8 (C13), 110.5 (C6), 67.0 (C8), 60.5 (C7), 58.4 (C9), 55.5 (C16), 55.4 (C17). For
atom n um berin g, see Ch art 1. HRMS (FAB+): for C18H19N2O3 (MH+) calculated: 311.1396;
foun d: 311.1396.
2
2
2
Collect. Czech. Chem. Commun. 2006, Vol. 71, No. 9, pp. 1278–1302